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Abstract Neurons are post-mitotic cells that undergo an
active downregulation of cell cycle-related proteins to sur-
vive. The activity of the anaphase-promoting complex/
cyclosome (APC/C), an E3 ubiquitin ligase that regulates
cell cycle progression in proliferating cells, plays a relevant
role in post-mitotic neurons. Recent advances in the study of
the regulation of APC/C have documented that the APC/C-
activating cofactor, Cdh1, is essential for the function(s) of
APC/C in neuronal survival. Here, we review the normal
regulation of APC/C activity in proliferating cells and neu-
rons. We conclude that in neurons the APC/C-Cdh1 com-
plex actively downregulates the stability of the cell cycle
protein cyclin B1 and the glycolytic enzyme 6-
phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3.
Keeping these proteins destabilized is critical both for pre-
venting the aberrant reentry of post-mitotic neurons into the
cell cycle and for maintaining their reduced antioxidant
status. Further understanding of the pathophysiological reg-
ulation of these proteins by APC/C-Cdh1 in neurons will be
important for the search for novel therapeutic targets against
neurodegeneration.
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Introduction
The cell cycle is an essential process for the develop-
ment, differentiation, and proliferation of eukaryotic
cells. Classically, the cell cycle is divided into four
phases, namely, G1, S, G2, and M. Proper progression
from one phase to the other is monitored by check-
points that sense possible defects during DNA synthesis
and chromosome segregation [1]. Progression through
the cell cycle is controlled by the appropriate and timely
activation of cell cycle proteins. This control is executed
by the ubiquitin proteasome system (UPS). The UPS
consists of sets of enzymes that target substrates to
proteasomal destruction by covalently attaching a poly-
ubiquitin chain in an enzymatic cascade [2]. First, ubiq-
uitin is covalently linked to the E1 ubiquitin-activating
enzyme in an energy (ATP)-dependent manner. Ubiqui-
tin is then transferred to the E2 ubiquitin-conjugating
enzyme. Finally, the E3 ubiquitin ligase recruits both
the E2 ubiquitin-conjugating enzyme and substrate, thus
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facilitating the transfer of ubiquitin to the lysine resi-
dues of the substrate. Polyubiquitinated substrates are
then recognized by the proteasome, which leads them
to degradation [2].
The specificity of the UPS is conferred by a large
and varied collection of E3 ubiquitin ligases. The cullin-
really interesting new gene (RING)-finger-type E3s con-
stitute one of the largest classes of E3s and are essential
for the maintenance of genomic integrity and cellular
homeostasis [3]. Two major cullin-RING-E3 ubiquitin
ligases, the SKP1-CUL1-F-box-protein (SCF) complex
and the anaphase-promoting complex, also called the
cyclosome (APC/C), are responsible for targeting cell
cycle proteins for degradation. Whereas SCF ubiquity-
lates substrates from late G1 to early M phase, the
APC/C is active from the onset of mitosis to the end
of the G1 phase of the cell cycle [4, 5]. Differentiated
cells, such as neurons, remain resting in the G0 phase
due to an active downregulation of cell cycle-related
proteins. However, recent evidence has indicated that
neurons retain the ability to reactivate the cell cycle in
response to central nervous system (CNS) insults. Thus,
neurons attempt to reenter the cell cycle under patho-
logical circumstances, including both acute injury and
chronic neurodegenerative disorders [6–8]. For instance,
in vivo evidence has revealed S phase entry in ischemic
neurons [9] and aberrant expression of mitotic cyclin B1
in degenerating neurons in Alzheimer’s disease [10].
Thus, dysregulation of the cell cycle machinery might
be a pathway common to several neurodegenerative
disorders and other CNS diseases [11]. It has recently
been reported that APC/C activity, which regulates cell
cycle progression in proliferating cells [12–14], is also
essential for neuronal survival [15, 16], linking prolifer-
ation to neurodegeneration. This review summarizes re-
cent findings describing the functions of APC/C in
neuronal cell death.
The APC/C Complex
The APC/C is a multi-subunit cullin-RING E3 ubiquitin
ligase assembled from 13 different core subunits that regu-
lates progression from metaphase to anaphase and exit from
mitosis [12–14, 17]. Among these subunits, the best-
characterized ones are the cullin and RING proteins Apc2
and Apc11, which are responsible for catalytic activity, the
tetratricopeptide (TPR) repeat subunit Apc3 (or Cdc27),
which interacts with co-activators, and the Apc10, also
known as Doc1 [17, 18]. The RING-finger protein Apc11
interacts directly with the Ub-conjugated E2 enzyme, while
the cullin domain of Apc2 interacts with the RING-finger
domain of Apc11, acting as a scaffold to connect Apc11 to
the enzyme [19].
Regulation of the APC/C in the Cell Cycle
The activity of the APC/C is tightly regulated along the cell
cycle. This is exerted through a combination of co-activator
subunits, reversible phosphorylation, and inhibitory proteins
and complexes [12–14]. To be active, the APC/C requires
the binding of either one of two WD40-domain co-activator
proteins, Cdc20 or Cdh1, which also participate in substrate
recognition [20–22]. The activators interact dynamically
with the TPR domains in Apc3 and may either facilitate
recruitment of substrates through their WD40 domains or
enhance the specific activity of the APC/C [23]. The TPR
subunit Apc3 also interacts with the Apc10 subunit [24].
Apc10 contains a β-barrel structure, known as the Doc
domain that is involved in substrate binding and recognition
[25, 26].
Activation of the APC/C by Cdc20 or Cdh1 is regulated
tightly and oppositely by phosphorylation events. In early
mitosis, cyclin–cyclin-dependent kinase (Cdk) complexes
phosphorylate some APC/C subunits, hence promoting the
binding of Cdc20 to the complex [27]. APC/C-Cdc20 thus
initiates a sequence of degradation of mitotic cyclins that
results in decreased Cdk activity, leading to the initiation of
anaphase. In contrast, the phosphorylation of Cdh1 by Cdks
during S phase, G2, and mitosis inhibits its binding to the
APC/C [28, 29]. During exit from mitosis, the inactivation
of Cdks and subsequent activation of phosphatases [30]
allows Cdh1 dephosphorylation, leading to the activation
of the APC/C-Cdh1 complex. In turn, APC/C-Cdh1 ubiq-
uitylates Cdc20, thus preventing the simultaneous activation
of both APC/C co-activators. APC/C-Cdh1 also targets A/B
types of mitotic cyclins for destruction, completing the
inactivation of Cdk1. In particular, cyclin B1 is degraded
in two phases, sequentially regulated by APC/C-Cdc20 and
APC/C-Cdh1 [31, 32]. Subsequently, during early mitosis,
Cdc20 activates APC/C, whereas in late mitosis APC/C-
Cdh1 activation controls mitotic exit and G1 maintenance,
thus regulating the onset of DNA replication [12–14].
Substrate Recognition by APC/C-Cdh1
APC/C-Cdc20 and APC/C-Cdh1 have different substrate
specificities, which allow the orchestration of cell cycle
protein degradation in the correct order. Selection of the
APC/C targets is controlled by the recognition of short
degron motifs, predominantly the destruction (D) box
(RxxLxxxxN) and the KEN box (KENxxxN) [17]. The D
box was first described to be necessary and sufficient for the
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APC/C-mediated ubiquitylation of B type cyclins [33–35].
The KEN motif is commonly present in APC/C substrates,
usually in addition to the D box [36]; however, some sub-
strates contain only either a D box or KEN box, in one or
more copies each. While the D box is recognized by both
APC/C-Cdc20 and APC/C-Cdh1, the latter also recognizes
targets with a KEN box motif [33, 36, 37]. Although the
presence of D and KEN box sequences in proteins is re-
quired for APC/C-mediated ubiquitination of many sub-
strates, it is often not sufficient. Other less known motifs,
such as the A box (RxLxPSN), the CRY (CRYxPS) box,
and the KEN-like GxEN box, have also been identified [38].
For instance, Aurora A contains both a D box and a KEN
box, but its recognition by APC/C-Cdh1 also requires the
destruction motif A box [39]. Furthermore, the APC/C-
Cdh1-dependent destruction of Cdc20 requires not only its
KEN box but also its CRY box [40]. Finally, Castro et al.
[41] identified a GxEN box within the C-terminus of XKid,
a protein involved in chromosome segregation in anaphase;
this GxEN box being necessary for its recognition and
association with APC/C.
Yamano et al. [42] described a direct interaction of the
APC/C core with substrates via the degron motifs. The core
subunit Doc1/Apc10 appears to regulate the direct interac-
tion and binding of specific substrates [43, 44]. Site-directed
mutagenesis analyses in Apc10/Doc1 demonstrated that this
subunit specifically mediates D box-dependent recognition
[25]; however, Apc10/Doc1 does not participate in the rec-
ognition of KEN box by Cdh1. Recently, da Fonseca et al.
[26] have reported that Cdh1 and Doc1/Apc10 function as
the D box co-receptor.
Phosphorylation of Cdh1 and APC/C Activity
The activity of APC/C-Cdh1 increases in late anaphase and
is maintained elevated through the G1 phase of the cell
cycle, and it is tightly regulated through the reversible
phosphorylation of Cdh1 and its substrates, inhibitor pro-
teins, and Cdh1 degradation (Fig. 1). The phosphorylation
of Cdh1 by Cdk1 and Cdk2, which starts from G1/S transi-
tion to anaphase, blocks its own interaction and binding to
APC/C [28]. Recently, it has been described that Cdk5, a
member of the CNS predominant Cdk family that is essen-
tial for synaptic plasticity [45] and neurotoxicity [46, 47],
phosphorylates (and inactivates) Cdh1 [16].
It is known that Cdh1 dephosphorylation depends not
only on Cdk inactivation but also on phosphatase activation
[30]. In budding yeast, the main Cdh1 phosphatase, Cdc14,
mediates the activation of both Cdh1 and the Cdk1 inhibitor
protein Sic1, leading to the completion of Cdk1 inactivation
[48, 49]. However, although three homologues of yeast
Cdc14 (CDC14A, CDC14B, and CDC14C) have been
identified in vertebrates, their relevance remains unclear,
given the lack of a clear effect on mitotic exit [50–53]. By
contrast, mitotic exit in animal cells is independent of Cdc14
and, instead, relies on phosphatases of the PP1 and PP2A
families [30]. In this context, numerous studies suggest
functions of vertebrate Cdc14 that are unrelated to mitotic
exit, including roles in the DNA damage checkpoint [54],
DNA repair [53], and centrosome duplication and function
[51, 55]. In particular, in response to genotoxic stress in G2,
Cdc14B translocates from the nucleolus to the nucleoplasm,
where this phosphatase dephosphorylates Cdh1, hence pro-
moting APC/C-Cdh1 activity [54].
The phosphorylation of Cdh1 substrates also contributes
to the regulation of APC/C-Cdh1 activity. For example,
Cdk2-mediated phosphorylation of the SCF E3 ubiquitin
ligase cofactor, Skp2, disrupts its association with APC/C-
Cdh1, leading to Skp2 accumulation at the end of G1 phase
[56, 57]. On the other hand, Cdc14B-dependent dephos-
phorylation of Cdh1 promotes Skp2 degradation at the M/
G1 transition [58].
In addition to inhibitory phosphorylation by Cdks,
Cdh1 is also inhibited by Emi1, which acts as a pseu-
dosubstrate that inactivates APC/C-Cdh1 at G2 and the
G1/S transition [59–61]. Emi1 contains a D box motif
that mediates its own binding to APC/C-Cdh1, thus
blocking the accessibility of substrates to the enzyme.
Moreover, Emi1 also contains a ZBR motif that directly
inhibits APC/C E3 ligase activity [62].
The subcellular localization of Cdh1 provides an impor-
tant element of spatial regulation of APC/C-Cdh1 activity
[63, 64]. Cdh1 is located in the nuclei during G1 but redis-
tributes to the cytosol between S phase and the end of
Fig. 1 Regulation of APC/C-Cdh1 activity. The activity of APC/C-
Cdh1 is tightly regulated by reversible phosphorylation of Cdh1,
inhibitor proteins, and Cdh1 degradation. The phosphorylation of
Cdh1 by cyclin-Cdks blocks its own interaction and binding to APC/
C. Cdh1 dephosphorylation triggers APC/C-Cdh1 activation. Phos-
phorylated Cdh1 is translocated from the nuclei to the cytosol where
it is recognized and targeted for degradation by the SCF complex.
Cdh1 is also inhibited by Emi1, which acts as a pseudosubstrate that
inactivates APC/C-Cdh1 at G2 and G1/S transition. Finally, Cdh1
mediates its own degradation by stimulating APC/C activity, which
depends upon two D boxes
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mitosis [63]. Nuclear export of Cdh1 to the cytosol is
promoted by Cdk phosphorylation [16, 63], which seques-
ters Cdh1 from either the APC/C or nuclear targets, thus
contributing to the efficient inactivation of APC/C-Cdh1.
Furthermore, phosphorylated Cdh1 is recognized and tar-
geted for degradation by the SCF complex, the predominant
E3 ubiquitin ligase in S phase [65].
Finally, Listovsky et al. [66] have described that
APC/C activity is regulated by Cdh1 protein abundance.
The levels of Cdh1 are high in mitosis, when it is
inactive; however, when Cdh1 is active in G1 and G0,
its levels are considerably lower, although mostly asso-
ciated with APC/C. Those authors concluded that Cdh1
mediates its own degradation by stimulating APC/C
activity, which depends upon two D boxes [66]. In
addition, Rape and Kirschner [67] reported that APC/
C-Cdh1-mediated proteasomal degradation of the
ubiquitin-conjugating enzyme (E2) UbcH10 also pro-
vides a negative feedback mechanism that inactivates
APC/C-Cdh1 during the G1/S transition.
APC/C-Cdh1 in G0/G1 Regulation
As mentioned above, cyclin-Cdk complexes phosphorylate
Cdh1, inhibiting its binding to the APC/C complex [28, 29];
the concomitant inhibition of APC/C activity is released
when cyclin-Cdk activity decreases and Cdh1 phosphoryla-
tion stops in late mitosis. This leads to APC/C-Cdh1 reac-
tivation, which in turn maintains the cyclin B-Cdk1 inactive
during late mitosis [68]. In this phase, APC/C-Cdh1 also
mediates the degradation of regulators of cytokinesis and
centrosome replication, such as Aurora A, Aurora B, Plk1,
Anillin, and Tpx2, among other proteins [69, 70].
During G1, APC/C-Cdh1 remains active by maintaining
the activity of cyclin-Cdk complexes low. In this context,
active APC/C-Cdh1 targets A/B types of mitotic cyclins for
proteasomal degradation [71, 72]. Moreover, APC/C-Cdh1
can also inactivate Cdk activity by promoting the degrada-
tion of the Cdk activator, Cdc25A, and the two cofactors of
the SCF E3 ubiquitin ligase: Skp2 and Cks1. This leads to
the accumulation of Cdk inhibitors p21, p27, and p57 [56,
57]. APC/C-Cdh1 also limits the expression of cyclin D1
through the elimination of the transcription factor Ets2 [73].
Thus, depletion of Cdh1 by siRNA has been shown to
stabilize Skp2 and Ets2, resulting in p21 and p27 degrada-
tion and cyclin D1 elevation in G1, followed by a shorter G1
phase and premature entry into S phase [56, 73, 74]. More-
over, in Cdh1-deficient cells, the shortening of the G1 phase
is associated with a prolonged and defective S phase
[74–76]. As will be discussed below, in post-mitotic neu-
rons, Cdh1 depletion causes a reentry into the S phase of the
cell cycle followed by apoptotic cell death [15].
During G1, most cells commit alternatively to DNA
replication and division or to cell cycle exit and differenti-
ation. Because of its crucial role in G1/G0 regulation and
maintenance of quiescence, APC/C-Cdh1 has been pro-
posed to be responsible for linking cell cycle exit and
differentiation in certain cell types [14, 38] (Fig. 2). Bar-
On et al. [77] have recently described that APC/C-Cdh1-
mediated Skp2 degradation, and the subsequent p27 accu-
mulation are essential for human embryonic stem cell
differentiation.
APC/C-Cdh1 is also crucial for the coordination of cell
cycle progression and the initiation of lens [78] and muscle
cell [79] differentiation. APC/C-Cdh1-regulated lens differ-
entiation is mediated by transforming growth factor
(TGF)β-induced destruction of SnoN, a transcriptional re-
pressor of the Cdk inhibitors p15 and p21 (Fig. 2). Thus,
depletion of Cdh1 by RNA interference attenuates the
TGFβ-mediated induction of p15 and p21 and blocks lens
differentiation [78]. Furthermore, TGFβ induces Skp2 deg-
radation mediated by the Smad cascade, which stabilizes
p27 and p21 and thereby contributes to TGFβ-induced cell
cycle arrest [80]. In muscle, APC/C-Cdh1 regulates two
critical proteins, Skp2 and Myf5, for proteolysis during
muscle differentiation [79]. On the one hand, the targeting
of Skp2 by APC/C-Cdh1 for destruction results in an accu-
mulation of p21 and p27, which are crucial for coordinating
cellular division and differentiation. On the other hand, the
degradation of Myf5 facilitates myogenic fusion.
Fig. 2 APC/C-Cdh1 coordinates cell cycle arrest and cellular differ-
entiation. APC/C-Cdh1 inhibits cell proliferation by promoting the
degradation of Cdk activators, such as cyclins, and the stabilization
of Cdk inhibitors, including p27. APC/C-Cdh1 targets Skp2 for pro-
teasomal degradation, leading to p27 accumulation and cell cycle
arrest. Cyclin-Cdk complex phosphorylates Cdh1 and prevents APC/
C activation. TGFβ stimulates APC/C-Cdh1-mediated SnoN degrada-
tion, leading to activation of TGFβ target genes and growth inhibition.
APC/C-Cdh1 also triggers Id2 (inhibitor of differentiation/DNA bind-
ing 2) degradation. This promotes the activation of basic helix-loop-
helix transcription factors and targets gene expression that mediates
cellular differentiation
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APC/C-Cdh1 in Neuronal Differentiation
The activation of APC/C-Cdh1 is also required for neuronal
differentiation. It has been reported that APC/C-Cdh1 medi-
ates retinoic acid-induced neuronal differentiation from SH-
SY5Y neuroblastoma cells [74]. Thus, retinoic acid induces
the nuclear accumulation of Cdh1 that parallels Skp2 desta-
bilization and p27 accumulation. Furthermore, retinoic acid
decreases the mRNA and protein levels of Rae1—a nuclear
export factor that limits APC/C-Cdh1 activity in mitosis—
hence facilitating APC/C-Cdh1-mediated Skp2 degradation,
leading to cell cycle arrest and neuroblastoma differentiation
[74]. The regulation of this Skp2-p27 axis by APC/C-Cdh1
has also been found to be involved in the terminal differen-
tiation of neuronal precursors in response to nerve growth
factor [81].
Finally, APC/C-Cdh1 regulates axonal growth and pat-
terning through the degradation of two nuclear proteins,
namely, the inhibitor of differentiation/DNA binding 2
(Id2) and SnoN [82, 83] (Fig. 2). In the developing nervous
system, Id2 enhances cell proliferation, promotes tumor
progression, and inhibits the activity of neurogenic basic
helix-loop-helix transcription factors [84]. Lasorella et al.
[82] demonstrated that APC/C-Cdh1 targets Id2 for degra-
dation through a D box motif that is conserved in Id1 and
Id4. Degradation of Id2 in neurons permits the accumulation
of the Nogo receptor and the subsequent inhibition of axonal
growth. Furthermore, Stegmuller et al. [83] found that the
Cdh1-dependent inhibition of TGFβ-SnoN axis stimulates
axonal growth.
Cyclin B1 Stability Regulation by APC/C-Cdh1
in Neuronal Survival
Several core subunits of APC/C and Cdh1 are highly
expressed in mammalian brain post-mitotic neurons [15,
85]. In neurons, depletion of Cdh1 by RNA interference
rapidly triggers apoptotic neuronal death. Thus, APC/C-
Cdh1 is required to maintain low levels of cyclin B1 in
order to prevent an aberrant entry into the cell cycle that
will lead to neuronal apoptosis (Fig. 3). Cdh1 then regulates
neuronal survival [15]. Under physiological conditions, glu-
tamate receptor-mediated excitatory neurotransmission
plays a central role in neural development, differentiation,
and synaptic plasticity. However, excessive or prolonged
activation of glutamate receptors induces neurotoxicity, a
process that has been defined as excitotoxicity [86, 87].
Excitotoxicity mediates neuronal death in several neurolog-
ical disorders, including stroke and chronic neurodegenera-
tive diseases [87, 88]. In a previous study, the changes in
cyclin B1 protein levels following an excitotoxic stimulus
caused by a short (5 min) incubation of post-mitotic cortical
neurons with glutamate (100 μM) or the specific glutamate
receptor subtype agonist, N-methyl-D-aspartate (NMDA;
100 μM) were investigated. Under these conditions, neurons
died in an NMDA receptor-dependent manner [89]. Western
blot analyses of neurons revealed that both glutamate and
NMDA promoted an accumulation of cyclin B1 in the
neuronal nuclei that was fully prevented by silencing cyclin
B1 [16]. Furthermore, cyclin B1 nuclear accumulation was
responsible for a large proportion of the apoptotic death
caused by glutamate and NMDA. It was also found that
glutamate and NMDA triggered Cdh1 phosphorylation, se-
questering Cdh1 in the cytosol and inhibiting APC-Cdh1
activity.
Using both the Cdk inhibitor roscovitine and an RNA
interference strategy, it was also demonstrated that Cdh1 was
phosphorylated by Cdk5, an enzyme that can be persistently
activated when bound to p25 [46], the proteolytic product of
p35 that has previously been shown to accumulate in the
neurons of patients with Alzheimer’s disease [90]. It was
found that Cdk5 small interfering RNA dose-dependently
prevented the apoptotic neuronal death triggered by NMDA
and glutamate. These data were the first to suggest that
NMDA receptor stimulation activates Cdk5, which phosphor-
ylates Cdh1, leading to cyclin B1 accumulation and neuronal
apoptotic death [16]. It is interesting to note that Cdk5 phos-
phorylates the NMDA receptor NR2A subunit at Ser-1232,
hence facilitating NMDA receptor synaptic transmission [91].
Thus, NMDA receptor overactivation, which occurs in pro-
longed release of the neurotransmitter glutamate such as that
occurring in neurodegenerative diseases and stroke [88], could
lead to a Cdk5-NMDA receptor activation feedback loop,
contributing to the propagation of neurodegeneration.
Fig. 3 APC/C-Cdh1 regulates neuronal apoptosis. Excitotoxicity-
induced Cdk5-p25 activation phosphorylates Cdh1. APC/C-Cdh1 in-
activation causes the stabilization of the cell cycle protein cyclin B1
and the glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase-3 (PFKFB3). Stabilization of these proteins induces
both aberrant reentry of post-mitotic neurons into the cell cycle and
oxidative stress, leading to neuronal apoptosis
Mol Neurobiol (2012) 46:547–554 551
Interestingly, cyclin B1 accumulates in degenerating brain
areas in Alzheimer’s disease [10, 92] and stroke [93], which
are situations known to be associated with an excitotoxic-type
neuronal death [88]. Thus, these data suggest that Cdk5-
mediated Cdh1 inactivation might contribute to neuronal
death in neurological disorders.
APC/C-Cdh1 in Glucose Metabolism and Oxidative
Stress: Role in Neurodegeneration
Neurons are the highest energy-consuming cells of the
brain; however, the rate of glycolysis, the metabolic route
responsible for the generation of most energy needs in cells,
is very low in neurons, particularly in comparison with their
neighboring astrocytes [94, 95]. Glucose-derived glucose-6-
phosphate is the connecting metabolite between glycolysis
and the pentose-phosphate pathway (PPP) [96]. The PPP is
the main metabolic pathway responsible for the regeneration
of NADPH(H+), a required reducing cofactor for many
oxidoreductases. Previously, it has been found that in corti-
cal neurons the protein abundance of the glycolytic enzyme
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, iso-
form 3 (PFKFB3) is very low in neurons as compared with
that found in astrocytes [95]. This was considered impor-
tant, since PFKFB3 is a key enzyme controlling the rat of
glycolysis, and hence energy generation from glucose. Fur-
thermore, it was found that overexpressing PFKFB3 in
neurons increased the rate of glycolysis, although it con-
comitantly decreased that of the PPP [97].
Interestingly, PFKFB3 protein was found to be a sub-
strate of APC/C-Cdh1 [97]. Accordingly, APC/C-Cdh1 ac-
tivity determines the control of the rate of glucose
consumption both through glycolysis and the PPP. In con-
trast to neurons, astrocytes express a very low Cdh1 protein
abundance, and hence APC/C activity is negligible in these
cells [97]. Knocking down Cdh1 in neurons inhibits APC/C-
Cdh1 activity and leads PFKFB3 protein to accumulate,
thus shifting glucose consumption towards glycolysis at
the expense of a reduction in that of the PPP. Importantly,
this causes an impairment in neurons to regenerate NADPH
(H+), hence promoting oxidative stress by promoting the
oxidation of antioxidant glutathione [97].
This tight regulation of glycolysis and PPP by APC/C-
Cdh1 has important consequences for neuronal survival.
Thus, when the activation of the rate of glycolysis is pro-
longed by inhibiting APC/C-Cdh1 activity, neurons undergo
apoptotic death [97]; moreover, neuronal death can be fully
reversed by incubation with a plasma membrane-permeable
form of glutathione [97]. Thus, glucose is preferentially uti-
lized through the PPP to exert antioxidant-mediated neuro-
protection, and APC/C-Cdh1 activity is essential to control
this physiological function. Future studies will be needed to
understand whether Cdh1 deficiency or the inhibition of APC/
C activity exert any role in the mechanism leading to
neurodegeneration.
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